Sveits -
italiensk -
Swissmedic (Swiss Agency for Therapeutic Products)
calciumfolinat sandoz eco 1000 mg iniezione/infusione
sandoz pharmaceuticals ag - acido folinicum - iniezione/infusione - acidum folinicum 1000 mg ut calcii folinas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 100 ml. - antidoto contro folsäureantagonisten - antidota
Sveits -
italiensk -
Swissmedic (Swiss Agency for Therapeutic Products)
leucovorin-teva 50 mg / 5 ml iniezione/infusione
teva pharma ag - acido folinicum - iniezione/infusione - acidum folinicum 50 mg ut calcii folinas, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 5 ml corresp. natrium 16.3 mg. - antidoto contro l'acido folico-antagonisti - antidota
Sveits -
italiensk -
Swissmedic (Swiss Agency for Therapeutic Products)
leucovorin-teva 100 mg / 10 ml iniezione/infusione
teva pharma ag - acido folinicum - iniezione/infusione - acidum folinicum 100 mg ut calcii folinas, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 10 ml corresp. natrium 32.7 mg. - antidoto contro l'acido folico-antagonisti - antidota
Sveits -
italiensk -
Swissmedic (Swiss Agency for Therapeutic Products)
leucovorin-teva 200 mg / 20 ml iniezione/infusione
teva pharma ag - acido folinicum - iniezione/infusione - acidum folinicum 200 mg ut calcii folinas, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 20 ml corresp. natrium 65.3 mg. - antidoto contro l'acido folico-antagonisti - antidota
Sveits -
italiensk -
Swissmedic (Swiss Agency for Therapeutic Products)
leucovorin-teva 300 mg / 30 ml iniezione/infusione
teva pharma ag - acido folinicum - iniezione/infusione - acidum folinicum 300 mg ut calcii folinas, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 30 ml corresp. natrium 98.0 mg. - antidoto contro l'acido folico-antagonisti - antidota
Sveits -
italiensk -
Swissmedic (Swiss Agency for Therapeutic Products)
leucovorin-teva 500 mg / 50 ml iniezione/infusione
teva pharma ag - acido folinicum - iniezione/infusione - acidum folinicum 500 mg ut calcii folinas, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 50 ml corresp. natrium 163.3 mg. - antidoto contro l'acido folico-antagonisti - antidota
Den europeiske union -
italiensk -
EMA (European Medicines Agency)
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - agenti antineoplastici - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.